NASDAQ:TRHC - Tabula Rasa HealthCare Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$61.83 +0.52 (+0.85 %)
(As of 06/24/2018 04:57 AM ET)
Previous Close$61.83
Today's Range$60.36 - $62.54
52-Week Range$12.63 - $62.97
Volume966,632 shs
Average Volume330,263 shs
Market Capitalization$1.23 billion
P/E Ratio-1,545.75
Dividend YieldN/A
Beta2.66
Tabula Rasa HealthCare logoTabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.

Receive TRHC News and Ratings via Email

Sign-up to receive the latest news and ratings for TRHC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:TRHC
CUSIPN/A
Phone866-648-2767

Debt

Debt-to-Equity Ratio0.01
Current Ratio0.45
Quick Ratio0.41

Price-To-Earnings

Trailing P/E Ratio-1,545.75
Forward P/E Ratio137.40
P/E Growth5.47

Sales & Book Value

Annual Sales$134.55 million
Price / Sales9.20
Cash Flow$0.5040 per share
Price / Cash122.67
Book Value$6.86 per share
Price / Book9.01

Profitability

EPS (Most Recent Fiscal Year)($0.04)
Net Income$14.29 million
Net Margins-0.61%
Return on Equity0.38%
Return on Assets0.22%

Miscellaneous

Employees536
Outstanding Shares20,010,000

The Truth About Cryptocurrencies

Tabula Rasa HealthCare (NASDAQ:TRHC) Frequently Asked Questions

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) released its earnings results on Tuesday, May, 8th. The company reported $0.10 earnings per share for the quarter, beating analysts' consensus estimates of $0.01 by $0.10. The company had revenue of $43.94 million for the quarter, compared to analysts' expectations of $42.60 million. Tabula Rasa HealthCare had a negative net margin of 0.61% and a positive return on equity of 0.38%. Tabula Rasa HealthCare's revenue for the quarter was up 57.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.08 EPS. View Tabula Rasa HealthCare's Earnings History.

When is Tabula Rasa HealthCare's next earnings date?

Tabula Rasa HealthCare is scheduled to release their next quarterly earnings announcement on Monday, August, 6th 2018. View Earnings Estimates for Tabula Rasa HealthCare.

What price target have analysts set for TRHC?

12 brokers have issued 1 year target prices for Tabula Rasa HealthCare's shares. Their forecasts range from $16.00 to $68.00. On average, they expect Tabula Rasa HealthCare's share price to reach $45.6364 in the next twelve months. View Analyst Ratings for Tabula Rasa HealthCare.

Who are some of Tabula Rasa HealthCare's key competitors?

Who are Tabula Rasa HealthCare's key executives?

Tabula Rasa HealthCare's management team includes the folowing people:
  • Dr. Calvin H. Knowlton, Co-Founder, Chairman & CEO (Age 68)
  • Dr. Orsula V. Knowlton BScPharm, PharmD, MBA, Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director (Age 49)
  • Mr. Brian W. Adams, CFO & Sec. (Age 36)
  • Mr. Michael Greenhalgh BScPharm, RPh, Chief Operating Officer
  • Ms. Andrea Carolan Speers, Corp. Controller & Chief Accounting Officer (Age 37)

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray acted as the underwriters for the IPO and Baird and Stifel were co-managers.

Has Tabula Rasa HealthCare been receiving favorable news coverage?

Media coverage about TRHC stock has been trending somewhat positive this week, according to Accern Sentiment. The research firm ranks the sentiment of news coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Tabula Rasa HealthCare earned a daily sentiment score of 0.09 on Accern's scale. They also assigned media coverage about the company an impact score of 45.67 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

Who are Tabula Rasa HealthCare's major shareholders?

Tabula Rasa HealthCare's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (8.17%), Hood River Capital Management LLC (4.47%), Allianz Asset Management GmbH (1.03%), Allianz Asset Management GmbH (1.03%), Wasatch Advisors Inc. (0.92%) and Pier Capital LLC (0.76%). Company insiders that own Tabula Rasa HealthCare stock include Brian W Adams, Bruce Luehrs, Calvin H Knowlton, Glen R Bressner, Gordon Tunstall, Growth Fund 1Q Lp Originate, Joann M Durham and Orsula V Knowlton. View Institutional Ownership Trends for Tabula Rasa HealthCare.

Which major investors are selling Tabula Rasa HealthCare stock?

TRHC stock was sold by a variety of institutional investors in the last quarter, including Pier Capital LLC, Granite Investment Partners LLC, Wasatch Advisors Inc., Citadel Advisors LLC, California Public Employees Retirement System and Next Century Growth Investors LLC. Company insiders that have sold Tabula Rasa HealthCare company stock in the last year include Bruce Luehrs, Calvin H Knowlton, Gordon Tunstall, Growth Fund 1Q Lp Originate and Orsula V Knowlton. View Insider Buying and Selling for Tabula Rasa HealthCare.

Which major investors are buying Tabula Rasa HealthCare stock?

TRHC stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Braun Stacey Associates Inc., Principal Financial Group Inc., Principal Financial Group Inc., Intrinsic Edge Capital Management LLC, Osterweis Capital Management Inc., Tygh Capital Management Inc. and Bamco Inc. NY. Company insiders that have bought Tabula Rasa HealthCare stock in the last two years include Brian W Adams and Glen R Bressner. View Insider Buying and Selling for Tabula Rasa HealthCare.

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $61.83.

How big of a company is Tabula Rasa HealthCare?

Tabula Rasa HealthCare has a market capitalization of $1.23 billion and generates $134.55 million in revenue each year. The company earns $14.29 million in net income (profit) each year or ($0.04) on an earnings per share basis. Tabula Rasa HealthCare employs 536 workers across the globe.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at 866-648-2767 or via email at [email protected]


MarketBeat Community Rating for Tabula Rasa HealthCare (TRHC)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  129 (Vote Outperform)
Underperform Votes:  111 (Vote Underperform)
Total Votes:  240
MarketBeat's community ratings are surveys of what our community members think about Tabula Rasa HealthCare and other stocks. Vote "Outperform" if you believe TRHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.